Affluent Medical S.A.
AFME.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €53,117 | €53,626 | €31,729 | €105,788 |
| - Cash | €1,229 | €1,658 | €2,580 | €11,410 |
| + Debt | €16,329 | €17,134 | €17,735 | €19,751 |
| Enterprise Value | €68,217 | €69,102 | €46,884 | €114,129 |
| Revenue | €4,118 | €1,224 | €1,339 | €1,451 |
| % Growth | 236.4% | -8.6% | -7.7% | – |
| Gross Profit | -€9,272 | -€1,200 | -€1,104 | -€1,290 |
| % Margin | -225.2% | -98% | -82.4% | -88.9% |
| EBITDA | -€13,443 | -€13,343 | -€13,214 | -€10,888 |
| % Margin | -326.4% | -1,090.1% | -986.9% | -750.4% |
| Net Income | -€14,739 | -€15,653 | -€15,227 | -€14,820 |
| % Margin | -357.9% | -1,278.8% | -1,137.2% | -1,021.4% |
| EPS Diluted | -0.37 | -0.54 | -0.81 | -0.8 |
| % Growth | 31.5% | 33.3% | -1.3% | – |
| Operating Cash Flow | -€11,324 | -€12,054 | -€11,081 | -€12,364 |
| Capital Expenditures | -€147 | -€184 | -€146 | -€334 |
| Free Cash Flow | -€11,471 | -€12,238 | -€11,227 | -€12,698 |